Acute myeloid leukemia: open trials in China

226 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07925190
A Phase III Study Comparing Mesutoclax + Azacitidine Versus Venetoclax + Azacitidine in Untreated Acute Myeloid Leukemia (AML) Patients
Trial Treatment · Phase 3 · Beijing InnoCare Pharma Tech Co., Ltd.
The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Registry updated 2026-11-09
NCT07925554
Interferon-α Maintenance in Favorable-Risk AML
Trial Treatment · Phase 2 · Peking University People's Hospital
Peking University People's Hospital, Beijing
Registry updated 2026-11-09
NCT07926607
Palbociclib, All-Trans Retinoic Acid, and Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Trial Treatment · Phase 1/2 · Second Affiliated Hospital of Nanchang University
Second Affiliated Hospital of Nanchang University, Nanchang
Registry updated 2026-11-09
NCT07919119
Risk Stratification Value of Deep NGS-MRD Detection in Acute Myeloid Leukemia Patients After Allo-HSCT
Research · Institute of Hematology & Blood Diseases Hospital, China
National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital, Tianjin
Registry updated 2026-11-05
NCT07904884
MAC vs RIC for Transplantation in FLT3-ITD-Mutated AML Guided by UHS-NGS MRD ( FLT3 - MAC vs RIC )
Trial Treatment · First Affiliated Hospital of Zhejiang University
The First Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang
Registry updated 2026-11-04
NCT06852222
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Peking University First Hospital, Beijing · Peking University People's Hospital, Beijing · Peking University Third Hospital, Beijing · The first Affiliated Hospital of Jilin University, Changchun · Sichuan Provincial Peoples Hospital, Chengdu · West China Hospital Si Chuan University, Chengdu · The First Affiliated Hospital of Chongqing Medical University, Chongqing · Sun Yat-sen University Cancer Center, Guangzhou · The First Affiliated Hospital Zhejiang University College of Medicine, Hangzhou · The First Affiliated Hospital of USTC(Anhui Provincial Hospital), Hefei · Qilu Hospital of Shandong University, Jinan · The Second Hospital & Clinical Medical School Lanzhou University, Lanzhou · The First Affiliated Hospital of NanChang University, Nanchang · Zhongda Hospital Southeast University, Nanjing · The First Affiliated Hospital of Guangxi Medical University, Nanning · Shengjing Hospital Of China Medical University, Shenyang · The Second People's Hospital of Shenzhen, Shenzhen · First Affiliated Hospital SooChow University, Suzhou · Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tijian · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology, Wuhan · Union Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan · The First Affiliated hospital of Xiamen University, Xiamen · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an · Henan Cancer Hospital, Zhengzhou
Registry updated 2026-11-03
NCT07914556
Phase 1 Study of 6MW5311 in Adults With Relapsed or Refractory Blood Cancers
Trial Treatment · Phase 1 · Mabwell (Shanghai) Bioscience Co., Ltd.
Shanghai Jiao Tong University School of Medicine - Ruijin Hospital, Shanghai
Registry updated 2026-11-03
NCT03222674
Multi-CAR T Cell Therapy for Acute Myeloid Leukemia
Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-11-02
NCT04033302
Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies
Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-11-02
NCT05995028
Universal 4SCAR7U Targeting CD7-positive Malignancies
Trial Treatment · Phase 1 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-11-02
NCT05995041
Universal CAR-T Cells Targeting AML
Trial Treatment · Phase 1 · Shenzhen Geno-Immune Medical Institute
Shenzhen Geno-immune Medical Institute, Shenzhen
Registry updated 2026-11-02
NCT07897136
CLL-1/CD70 Dual-Target CAR-T Cell Therapy for Acute Myeloid Leukemia
Trial Treatment · Phase 1 · Liping Dou
Chinese PLA General Hospital, Beijing
Registry updated 2026-10-27
NCT07132684
Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients
Trial Treatment · Phase 3 · Institute of Hematology & Blood Diseases Hospital, China
Blood Diseases Hospital, Tianjin
Registry updated 2026-10-26
NCT07539818
Azacitidine + Venetoclax VS Azacitidineas Maintenance Therapy in AML
Trial Treatment · Phase 3 · Institute of Hematology & Blood Diseases Hospital, China
Blood Diseases Hospital, Tianjin
Registry updated 2026-10-26
NCT07014449
Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia
Trial Treatment · Phase 1 · Hangzhou Weben Pharma Co., Ltd
The first Affiliated Hospital, School of Medicine, Zhejiang University., Hangzhou
Registry updated 2026-10-16
NCT07616089
Phase I Study of FXS0683 in the Treatment of Blood Tumors
Trial Treatment · Phase 1 · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), Tianjin
Registry updated 2026-10-14
NCT07078591
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
Trial Treatment · Phase 2 · Beijing 302 Hospital
Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing
Registry updated 2026-10-13
NCT07841002
CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia
Trial Treatment · Phase 1 · Liping Dou
Chinese PLA General Hospital, Beijing, Beijing 100853, Beijing
Registry updated 2026-10-02
NCT06820268
A Study of XS-04 in Patients With Relapsed or Refractory Hematologic Malignancies
Trial Treatment · Phase 1 · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Beijing Cancer Hospital, Beijing · Sun Yat-Sen University Cancer Center, Guangdong · Affiliated Hospital of Hebei University, Hebei · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei
Registry updated 2026-09-25
NCT06824168
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Trial Treatment · Phase 2 · Daiichi Sankyo
Peking Union Medical College Hospital, Beijing · Peking University Third Hospital, Beijing · The First Hospital of Jilin University, Changchun · Guangdong Provincial People's Hospital, Guangzhou · Nanfang Hospital of Southern Medical University, Guangzhou · Sun Yat-sen University Cancer Center, Guangzhou · The First Affiliated Hosptial of Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of NanChang University, Nanchang · Zhong Da Hospital, Southeast University, Nanjing · The First Affiliated Hospital of Guangxi Medical University, Nanning · The Affiliated Hospital of Qingdao University, Qingdao · Huashan Hospital, Fudan University, Shanghai · The First Affiliated Hospital of Soochow University, Suzhou · Hematology Hospital of the Chinese Academy of Medical Sciences, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · The First Affiliated hospital of Xiamen University, Xiamen · The First Affiliated Hospital of Jiaotong University, Xi'an · The Affiliated Hospital of Xuzhou Medical College, Xuzhou · The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Registry updated 2026-09-16
NCT04771130
A Study of BGB-11417 in Participants With Myeloid Malignancies
Trial Treatment · Phase 1/2 · BeOne Medicines
Peking University Peoples Hospital, Beijing · West China Hospital，Sichuan University, Chengdu · Nanfang Hospital, Southern Medical University, Guangzhou · Guangdong Provincial Peoples Hospital, Guangzhou · The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou · The First Hospital of Lanzhou University, Lanzhou · The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang · The Second Peoples Hospital of Shenzhen, Shenzhen · The First Affiliated Hospital of Soochow University, Suzhou · Tianjin Medical University Cancer Institute and Hospital, Tianjin · Union Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan · Henan Cancer Hospital, Zhengzhou
Registry updated 2026-09-14
NCT05641259
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
Trial Treatment · Phase 1 · Guangzhou Lupeng Pharmaceutical Company LTD.
The First Affiliated Hospital of NanChang University, Nanchang · First Affiliated Hospital of Soochow University, Suzhou · Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou
Registry updated 2026-09-11
NCT07676006
A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Trial Treatment · Early phase 1 · Grit Biotechnology
Shenzhen People's Hospital, Shenzhen
Registry updated 2026-09-11
NCT07255872
A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Trial Treatment · Phase 2/3 · Sichuan Baili Pharmaceutical Co., Ltd.
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin
Registry updated 2026-09-10
NCT07813390
Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure
Trial Treatment · Phase 2 · Guangdong Second Provincial General Hospital
Guangdong Second Provincial General Hospital, Guangzhou
Registry updated 2026-09-10

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error